UPLC chromatography column ACQUITY

for pharmaceutical researchfor proteomics

Increasing sample throughput, achieving unmatched resolution, and improving analyte sensitivity are priorities for your separation goals. With Waters ACQUITY UPLC Columns, you can meet all your method requirements and substantially reduce your analysis time and cost-per-sample. Waters ACQUITY UPLC Columns’ sub-2-μm particle chemistries enable chromatographers to harness the separation efficiency improvements at increased flow rates of ultra-performance liquid chromatography (UPLC) technology, thereby improving analyte resolution and sensitivity as well as business productivity and profitability. Overview Best-in-class column efficiency for superior separation speed, sensitivity, and resolution 8 UPLC particles of various substrate technologies, including Ethylene Bridged Hybrid (BEH), High Strength Silica (HSS), and Charged Surface Hybrid (CSH) 22 stationary phases, including C18, Phenyl-Hexyl, C8, Embedded-Polar, C4, HILIC, Amide, Diol, Cyano, and PFP 7 application-specific UPLC Column chemistries for SEC, proteins, peptides, oligonucleotides, glycan, and amino acid analysis More than 50 different column dimensions and configurations, with internal column diameters ranging from 1.0–4.6 mm and column lengths ranging from 30–300 mm Prolonged column lifetimes with optional VanGuard Cartridges specifically designed using ACQUITY stationary phases ACQUITY UPLC BEH Column Characteristics ACQUITY UPLC BEH C18 Columns Universal C18 column Suitable for a diverse range of analytes High efficiency Industry-leading mobile phase pH 1-12 and temperature compatibility ACQUITY UPLC BEH C8 Columns Lower hydrophobicity and retention than a C18 column